Jan Dürig Selected Research

Testicular Neoplasms (Testicular Cancer)

10/2017

Frequency of expression and generation of T-cell responses against antigens on multiple myeloma cells in patients included in the GMMG-MM5 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jan Dürig Research Topics

Disease

18	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023 - 04/2004
17	Neoplasms (Cancer) 01/2022 - 02/2005
12	Multiple Myeloma 02/2024 - 10/2017
5	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 01/2022 - 09/2009
5	Disease Progression 01/2017 - 04/2003
4	Lymphoma (Lymphomas) 12/2023 - 09/2010
4	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2023 - 10/2018
4	Residual Neoplasm 01/2023 - 01/2021
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 04/2024 - 09/2021
3	Infections 12/2023 - 02/2005
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2023 - 01/2022
3	B-Cell Lymphoma (Lymphoma, B Cell) 04/2019 - 09/2009
2	Septic Shock (Toxic Shock Syndrome) 02/2024 - 11/2022
2	Large Granular Lymphocytic Leukemia 01/2023 - 11/2022
2	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 12/2017
2	Fever (Fevers) 12/2017 - 01/2010
2	Anemia 01/2016 - 06/2013
1	Pneumonia (Pneumonitis) 02/2024
1	Pulmonary Embolism 02/2024
1	Colitis 02/2024
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 02/2024
1	Meningoencephalitis 02/2024
1	Sepsis (Septicemia) 02/2024
1	Paraproteinemias (Monoclonal Gammopathy) 12/2023
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023
1	T-Cell Leukemia (Leukemia, T Cell) 11/2022
1	Leukemia 11/2022
1	Renal Insufficiency (Renal Failure) 11/2022
1	Heart Arrest (Cardiac Arrest) 11/2022
1	Enteritis 11/2022
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2022
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 12/2020
1	Second Primary Neoplasms (Neoplasms, Second) 10/2018
1	Cryoglobulinemia 01/2018
1	Trisomy (Trisomies) 01/2018
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 12/2017
1	Aspergillosis 12/2017
1	Mycoses (Diseases, Fungus) 12/2017
1	Monoclonal Gammopathy of Undetermined Significance 11/2017
1	Testicular Neoplasms (Testicular Cancer) 10/2017
1	Lymphadenopathy 01/2017

Drug/Important Bio-Agent (IBA)

8	Rituximab (Mabthera)FDA Link 04/2024 - 10/2018
7	Bortezomib (Velcade)FDA Link 04/2024 - 01/2021
7	Lenalidomide (CC 5013)FDA Link 02/2024 - 01/2016
6	Dexamethasone (Maxidex)FDA LinkGeneric 04/2024 - 01/2021
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2004
5	Proteins (Proteins, Gene)FDA Link 12/2023 - 07/2012
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 06/2011
4	ibrutinibIBA 01/2023 - 01/2021
4	obinutuzumabIBA 01/2023 - 10/2018
3	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2024 - 09/2021
3	Vincristine (Oncovin)FDA LinkGeneric 01/2023 - 10/2018
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 10/2018
3	Prednisone (Sone)FDA LinkGeneric 01/2023 - 10/2018
3	ofatumumab FDA Link 01/2021 - 06/2011
2	Monoclonal AntibodiesIBA 02/2024 - 11/2022
2	Immunoglobulin M (IgM)IBA 12/2023 - 01/2018
2	venetoclaxIBA 01/2023 - 01/2022
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2022 - 01/2020
2	Melphalan (Alkeran)FDA LinkGeneric 11/2022 - 01/2021
2	pomalidomideIBA 01/2022 - 01/2021
2	Bendamustine Hydrochloride FDA Link 01/2021 - 10/2018
2	AntigensIBA 10/2017 - 09/2004
2	fludarabineIBA 01/2017 - 06/2011
2	Hemoglobins (Hemoglobin)IBA 01/2016 - 06/2013
2	Messenger RNA (mRNA)IBA 09/2012 - 12/2009
2	DNA (Deoxyribonucleic Acid)IBA 09/2009 - 04/2004
1	elotuzumabIBA 02/2024
1	Cisplatin (Platino)FDA LinkGeneric 01/2023
1	Dihydrotachysterol (AT 10)IBA 01/2023
1	isatuximabIBA 11/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	Interferon-alpha (Interferon Alfa)IBA 09/2021
1	AntibodiesIBA 01/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021
1	Alemtuzumab (Campath)FDA Link 12/2020
1	Immunomodulating AgentsIBA 01/2019
1	Carrier Proteins (Binding Protein)IBA 01/2019
1	GalliumIBA 10/2018
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2018
1	Cyclin-Dependent Kinase 9IBA 05/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2018
1	liposomal amphotericin B FDA Link 12/2017
1	Voriconazole (Vfend)FDA LinkGeneric 12/2017
1	Inosine Triphosphate (ITP)IBA 12/2017
1	Nitrogen DioxideIBA 11/2017
1	Particulate MatterIBA 11/2017
1	CytokinesIBA 07/2017
1	B7-H1 AntigenIBA 07/2017
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2017

Therapy/Procedure

17	Therapeutics 04/2024 - 01/2010
8	Drug Therapy (Chemotherapy) 01/2023 - 04/2003
6	Stem Cell Transplantation 02/2024 - 01/2021
2	Radiotherapy 08/2019 - 12/2018
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2023
1	Chemoradiotherapy 01/2023
1	Transplantation 11/2022
1	Immunotherapy 01/2021
1	Hematopoietic Stem Cell Transplantation 12/2020